QUICK HEAL TECH LTD vs WIPRO LTD

A side-by-side comparison of QUICK HEAL TECH LTD (QUICKHEAL) and WIPRO LTD (WIPRO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, WIPRO LTD leads QUICKHEAL vs WIPRO on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

-69.20
P/E ratio
14.11
2.14
P/B ratio
2.07
2.19%
Dividend yield
1.13%
₹-2.01
EPS
₹12.58

Profitability

WIPRO takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-2.49%
Return on equity
15.50%
-5.00%
Return on capital
18.00%
-11.00%
EBITDA margin
19.00%
-4.21%
Net margin
14.32%

Growth

WIPRO takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-2.08%
Revenue CAGR (3Y)
0.78%
Profit CAGR (3Y) even
5.29%

Size & financial health

WIPRO takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹749 Cr
Market cap
₹1.91L Cr
₹261 Cr
Revenue
₹92,624 Cr
₹-11 Cr
Net profit
₹13,266 Cr
0.00
Debt / equity
0.13
QUICK HEAL TECH LTD
  • + ["Company is almost debt free."]
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -4.76% over past five years.", "Company has a low return on equity of 1.11% over last 3 years.", "Company has high debtors of 192 days.", "Company's cost of borrowing seems high", "Working capital days have increased from 188 days to 346 days"]
WIPRO LTD
  • + ["Stock is providing a good dividend yield of 6.08%.", "Company has been maintaining a healthy dividend payout of 46.7%"]
  • ["The company has delivered a poor sales growth of 8.38% over past five years."]
QUICK HEAL TECH LTD full analysis WIPRO LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.